Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
When redeeming rewards, several factors can influence your choices. Learn what to consider to ensure you get the best value for your points.
17,088 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
MortgageOne TPO announces an ARIVE integration alongside the Pathway CDFI loan program, aiming to broaden homeownersh...
A Polymarket admin wallet on the Polygon network was compromised, with investigators estimating losses above $600,000...
Investors watch a sharpened geopolitical debate over rare earths as China tightens grip on key materials and the US a...
Drew Barrymore’s 280-year-old Westchester weekend retreat has secured a buyer, after listing for $4.99 million. The d...
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Microsoft’s stock has drifted lower this year even as its AI and cloud businesses show stronger momentum. This piece ...
Nvidia CEO Jensen Huang reiterates a generous pay policy as AI-driven profits soar, highlighting how wealth from tech...
IBM's Justina Nixon-Saintil oversees a sweeping retraining drive aimed at 30 million workers by 2030, signaling a shi...
IonQ shows a real enterprise backlog totaling hundreds of millions, while Rigetti burns cash with declining revenue. ...
As WWDC 2026 opens, Apple faces a pivotal moment: Tim Cook's leadership transition and a bold AI strategy that could ...
Netflix has staged a comeback that rewards patient investors, but the last year also exposed two distinct paths for t...